Healthcare Professional Eye-Tracking Study

Disclosures in Professional and Consumer Prescription Drug Promotion

Appendix D - Questionnaires

Healthcare Professional Eye-Tracking Study

OMB: 0910-0860

Document [docx]
Download: docx | pdf

Appendix D: Questionnaires


Consumer Pretest Questionnaire


Programmer Notes


Participants should not be able to go back in the survey, only forward.


Unless otherwise indicated, only one question should appear per screen.


Require an answer to all screener questions. Prompt for an answer to all other questions: “Are you sure you don’t want to provide a response?”


For all Likert scale questions, flip scale for half of participants (randomize); scale orientation should be consistent for each respondent (e.g., a respondent should see either all high/positive options on the left or all low/negative options on the left).


//MAIN STUDY INTRODUCTION TEXT//


INTRODUCTION

Thank you for agreeing to participate in this study today. This study is about advertisements for prescription medications. We will show you some ads and then ask you some questions about them. If you typically wear glasses or contacts for reading or using a computer or mobile device, please make sure to wear them while viewing these materials. Please maximize your browser window so you can easily view the ads.


//NEW SCREEN//


INSTRUCTIONS

You will now see a series of pages from ads for medications used to treat health conditions that may affect you or your loved ones at some point during your lives. Please take a few moments to read and think about each ad as it is shown, and imagine you have the health condition that the medication is meant to treat.


PROGRAMMER:

  • Randomize the following blocks: Zoridtic, Eproquant, Desyflux (each block includes an ad followed by an assortment of questions)

  • Randomize disclosure condition within each drug type (each disclosure condition should be shown an equal number of times for each drug)

  • Show each ad for 30 seconds, then show a “Next” button for participants to advance at their own pace

  • For all questions about a specific drug, show the logo of the relevant drug at the top of the screen. Placement should be consistent for each question and each drug.

  • Omit internal notes (shown in red).

  • Additional data required for each participant:

    • Device type

    • Operating system

    • Browser type

    • Resolution (when possible)

    • Amount of time spent on each ad (in seconds)

    • Ad order for each ad

    • Disclosure condition for each ad

    • Page and question order as noted throughout







//ZORIDTIC BLOCK//


//NEW SCREEN//


BLOCK INSTRUCTIONS

Click the blue button when you are ready to view the next ad. After 30 seconds, a button will appear to allow you to advance, but please take as long as you need to view the ad. You can move your mouse over the ad to magnify any area.


//NEW SCREEN//


PROGRAMMER: Show randomly assigned Zoridtic ad for 30 seconds, then show a “Next” button for participants to advance at their own pace


//NEW SCREEN//


Question Type: Single Punch

  1. Were you able to see and read the Zoridtic ad on your device?


Variable Label: Q1: Were you able to see and read the Zoridtic ad on your device?


Value

Value Label

00

No [Go to demographic Qs before terminating]

01

Yes

-99

Refused [Terminate]



//NEW SCREEN//


We are now going to ask you some questions about Zoridtic. Please answer the following questions and provide as much detail as possible where appropriate. Even if you don’t remember some information about Zoridtic, please try your best to answer all of the questions.


Question Type: Essay

  1. According to the ad, what is Zoridtic used for? [Unaided recall]


Variable Label: Q2: According to the ad, what is Zoridtic used for?


Value

Value Label

-99

Refused

-100

Valid skip




Question Type: Essay

  1. What, if anything, did the ad mention Zoridtic is not approved for? [Unaided recall]


Variable Label: Q3: What, if anything, did the ad mention Zoridtic is not approved for?


Value

Value Label

-99

Refused

-100

Valid skip



[Randomize order of Q4 page and Q5 page; record order]


Question Type: Single Punch

  1. How effective do you think Zoridtic would be for helping you control high blood pressure? Please provide your best guess, based on what you read in the ad. [Efficacy]


Variable Label: Q4: How effective do you think Zoridtic would be for helping you control high blood pressure? Please provide your best guess, based on what you read in the ad.


Value

Value Label

01

Not at all effective

02

Slightly effective

03

Moderately effective

04

Mostly effective

05

Completely effective

-99

Refused

-100

Valid skip



Question Type: Single Punch

  1. How effective do you think Zoridtic would be for helping you prevent a heart attack or stroke? Please provide your best guess, based on what you read in the ad. [False claim perceptions]


Variable Label: Q5: How effective do you think Zoridtic would be for helping you prevent a heart attack or stroke? Please provide your best guess, based on what you read in the ad


Value

Value Label

01

Not at all effective

02

Slightly effective

03

Moderately effective

04

Mostly effective

05

Completely effective

-99

Refused

-100

Valid skip





[Randomize order of Q6–Q7; record order]


Question Type: Single Punch

  1. If you were diagnosed with high blood pressure, how likely would you be to seek additional information about Zoridtic from a source other than your health care provider? [Interest/information seeking intention]


Variable Label: Q8: If you were diagnosed with high blood pressure, how likely would you be to seek additional information about Zoridtic from a source other than your health care provider?


Value

Value Label

01

Very unlikely

02

Somewhat unlikely

03

Neither likely nor unlikely

04

Somewhat likely

05

Very likely

-99

Refused

-100

Valid skip



Question Type: Single Punch

  1. If you were concerned about heart attacks or strokes, how likely would you be to seek additional information about Zoridtic from a source other than your health care provider? [Interest/information seeking intention – incorrect]


Variable Label: Q9: If you were concerned about heart attacks or strokes, how likely would you be to seek additional information about Zoridtic from a source other than your health care provider?


Value

Value Label

01

Very unlikely

02

Somewhat unlikely

03

Neither likely nor unlikely

04

Somewhat likely

05

Very likely

-99

Refused

-100

Valid skip


[Randomize order of Q8–Q9; record order]

Question Type: Single Punch

  1. If you were diagnosed with high blood pressure, how likely would you be to ask your doctor for more information about Zoridtic? [Behavioral intention]


Variable Label: Q6: If you were diagnosed with high blood pressure, how likely would you be to ask your doctor for more information about Zoridtic?


Value

Value Label

01

Very unlikely

02

Somewhat unlikely

03

Neither likely nor unlikely

04

Somewhat likely

05

Very likely

-99

Refused

-100

Valid skip



Question Type: Single Punch

  1. If you were concerned about heart attacks or strokes, how likely would you be to ask your doctor for more information about Zoridtic? [Behavioral intention – incorrect]


Variable Label: Q7: If you were concerned about heart attacks or strokes, how likely would you be to ask your doctor for more information about Zoridtic?


Value

Value Label

01

Very unlikely

02

Somewhat unlikely

03

Neither likely nor unlikely

04

Somewhat likely

05

Very likely

-99

Refused

-100

Valid skip






Question Type: Grid

  1. Which of the following statements appeared in the ad for Zoridtic? Select all that apply. [Recognition of claim and disclosure]


Variable Label: Q10: Which of the following statements appeared in the ad for Zoridtic?


PROGRAMMER: Randomize order of all items


Variable Name

Variable Text

Variable Label

Q10_A

Zoridtic has not been tested as treatment or prevention for cardiovascular events, including heart attack and stroke

Q10_A: Zoridtic has not been tested as treatment or prevention for cardiovascular events, including heart attack and stroke

Q10_B

Zoridtic can significantly lower high blood pressure within 2 weeks

Q10_B: Zoridtic can significantly lower high blood pressure within 2 weeks

Q10_C

Medications that lower your blood pressure also lower your risk for heart attack and stroke

Q10_C: Medications that lower your blood pressure also lower your risk for heart attack and stroke

Q10_D

Zoridtic may increase your risk for heart attack or stroke

Q10_D: Zoridtic may increase your risk for heart attack or stroke

Q10_E

You should not take Zoridtic if you have diabetes

Q10_E: You should not take Zoridtic if you have diabetes

Q10_F

Zoridtic may cause headaches or dizziness

Q10_F: Zoridtic may cause headaches or dizziness



Value

Value Label

01

In ad

02

Not in ad

03

Don’t know

-99

Refused

-100

Valid skip



[Present Q11 and Q12 on same page]


Question Type: Single Punch

  1. How complicated would you say the information in the ad for Zoridtic was? [Cognitive load]


Variable Label: Q11: How complicated would you say the information in the ad for Zoridtic was?


Value

Value Label

01

Not at all complicated

02

Slightly complicated

03

Moderately complicated

04

Very complicated

05

Extremely complicated

-99

Refused

-100

Valid skip



Question Type: Single Punch

  1. How difficult was it to understand the Zoridtic ad? [Cognitive load]


Variable Label: Q12: How difficult was it to understand the Zoridtic ad?


Value

Value Label

01

Not at all difficult

02

Slightly difficult

03

Moderately difficult

04

Very difficult

05

Extremely difficult

-99

Refused

-100

Valid skip



//EPROQUANT BLOCK//


//NEW SCREEN//


BLOCK INSTRUCTIONS

Click the blue button when you are ready to view the next ad. After 30 seconds, a button will appear to allow you to advance, but please take as long as you need to view the ad. You can move your mouse over the ad to magnify any area.


//NEW SCREEN//

PROGRAMMER: Show randomly assigned Eproquant ad for 30 seconds, then show a “Next” button for participants to advance at their own pace


//NEW SCREEN//


Question Type: Single Punch

  1. Were you able to see and read the Eproquant ad on your device?


Variable Label: Q13: Were you able to see and read the Eproquant ad on your device?


Value

Value Label

00

No [Go to demographic Qs before terminating]

01

Yes

-99

Refused [Terminate]



//NEW SCREEN//


We are now going to ask you some questions about Eproquant. Please answer the following questions and provide as much detail as possible where appropriate. Even if you don’t remember some information about Eproquant, please try your best to answer all of the questions.


Question Type: Essay

  1. According to the ad, what is Eproquant used for? [Unaided Recall]


Variable Label: Q14: According to the ad, what is Eproquant used for?


Value

Value Label

-99

Refused

-100

Valid skip




Question Type: Essay

  1. What instructions, if any, did the ad mention for taking Eproquant? [Unaided Recall]


Variable Label: Q15: What instructions, if any, did the ad mention for taking Eproquant?


Value

Value Label

-99

Refused

-100

Valid skip



Question Type: Single Punch

  1. Based on the ad, how easy or hard do you think it would be to use Eproquant to help control your iron levels if you had chronic iron overload? [Ease of use]


Variable Label: Q16: Based on the ad, how easy or hard do you think it would be to use Eproquant to help control your iron levels if you had chronic iron overload?


Value

Value Label

01

Very hard

02

Somewhat hard

03

Neither easy nor hard

04

Somewhat easy

05

Very easy

-99

Refused

-100

Valid skip



Question Type: Single Punch

  1. Based on the ad, how easy or hard do you think it would be for you to make Eproquant part of your daily routine? [Ease of use]


Variable Label: Q17: Based on the ad, how easy or hard do you think it would be for you to make Eproquant part of your daily routine?


Value

Value Label

01

Very hard

02

Somewhat hard

03

Neither easy nor hard

04

Somewhat easy

05

Very easy

-99

Refused

-100

Valid skip




Question Type: Single Punch

  1. If you were diagnosed with chronic iron overload, how likely would you be to seek additional information about Eproquant from a source other than your health care provider? [Interest/information seeking intention]


Variable Label: Q19: If you were diagnosed with chronic iron overload, how likely would you be to seek additional information about Eproquant from a source other than your health care provider?


Value

Value Label

01

Very unlikely

02

Somewhat unlikely

03

Neither likely nor unlikely

04

Somewhat likely

05

Very likely

-99

Refused

-100

Valid skip




Question Type: Single Punch

  1. If you were diagnosed with chronic iron overload, how likely would you be to ask your doctor for more information about Eproquant? [Behavioral intention]


Variable Label: Q18: If you were diagnosed with chronic iron overload, how likely would you be to ask your doctor for more information about Eproquant?


Value

Value Label

01

Very unlikely

02

Somewhat unlikely

03

Neither likely nor unlikely

04

Somewhat likely

05

Very likely

-99

Refused

-100

Valid skip



Question Type: Grid

  1. Which of the following statements appeared in the ad for Eproquant? Select all that apply. [Recognition of claim and disclosure]


Variable Label: Q20: Which of the following statements appeared in the ad for Eproquant?


PROGRAMMER: Randomize order of all items


Variable Name

Variable Text

Variable Label

Q20_A

An example of a light meal is an English muffin and cottage cheese

Q20_A: An example of a light meal is an English muffin and cottage cheese

Q20_B

Take the exact number of tablets prescribed

Q20_B: Take the exact number of tablets prescribed

Q20_C

Eproquant is a simple to take, once-daily tablet

Q20_C: Eproquant is a simple to take, once-daily tablet

Q20_D

For maximum effectiveness, Eproquant must be taken with a meal containing less than 7% fat and about 250 calories

Q20_D: For maximum effectiveness, Eproquant must be taken with a meal containing less than 7% fat and about 250 calories

Q20_E

Do not take Eproquant with alcoholic beverages

Q20_E: Do not take Eproquant with alcoholic beverages

Q20_F

Before taking Eproquant, tell your doctor if you are pregnant or may become pregnant

Q20_F: Before taking Eproquant, tell your doctor if you are pregnant or may become pregnant



Value

Value Label

01

In ad

02

Not in ad

03

Don’t know

-99

Refused

-100

Valid skip



[Present Q21 and Q22 on same page]


Question Type: Single Punch

  1. How complicated would you say the information in the ad for Eproquant was? [Cognitive load]


Variable Label: Q21: How complicated would you say the information in the ad for Eproquant was?


Value

Value Label

01

Not at all complicated

02

Slightly complicated

03

Moderately complicated

04

Very complicated

05

Extremely complicated

-99

Refused

-100

Valid skip



Question Type: Single Punch

  1. How difficult was it to understand the Eproquant ad? [Cognitive load]


Variable Label: Q22: How difficult was it to understand the Eproquant ad?


Value

Value Label

01

Not at all difficult

02

Slightly difficult

03

Moderately difficult

04

Very difficult

05

Extremely difficult

-99

Refused

-100

Valid skip



//DESYFLUX BLOCK//


//NEW SCREEN//


BLOCK INSTRUCTIONS

Click the blue button when you are ready to view the next ad. After 30 seconds, a button will appear to allow you to advance, but please take as long as you need to view the ad. You can move your mouse over the ad to magnify any area.


//NEW SCREEN//


PROGRAMMER: Show randomly assigned Desyflux ad for 30 seconds, then show a “Next” button for participants to advance at their own pace


//NEW SCREEN//


Question Type: Single Punch

  1. Were you able to see and read the Desyflux ad on your device?


Variable Label: Q23: Were you able to see and read the Desyflux ad on your device?


Value

Value Label

00

No [Go to demographic Qs before terminating]

01

Yes

-99

Refused [Terminate]


//NEW SCREEN//


We are now going to ask you some questions about Desyflux. Please answer the following questions and provide as much detail as possible where appropriate. Even if you don’t remember some information about Desyflux, please try your best to answer all of the questions.


Question Type: Essay

  1. According to the ad, what is Desyflux used for? [Unaided Recall]


Variable Label: Q24: According to the ad, what is Desyflux used for?


Value

Value Label

-99

Refused

-100

Valid skip



Question Type: Essay

  1. What effects, if any, did Desyflux have in clinical trials? [Unaided Recall/Comprehension]


Variable Label: Q25: What effects, if any, did Desyflux have in clinical trials?


Value

Value Label

-99

Refused

-100

Valid skip

Question Type: Single Punch

  1. How effective do you think Desyflux would be for improving your lung function if you had COPD? Please provide your best guess, based on what you read in the ad. [Efficacy]


Variable Label: Q26: How effective do you think Desyflux would be for improving your lung function if you had COPD? Please provide your best guess, based on what you read in the ad.


Value

Value Label

01

Not at all effective

02

Slightly effective

03

Moderately effective

04

Mostly effective

05

Completely effective

-99

Refused

-100

Valid skip




Question Type: Single Punch

  1. If you were diagnosed with COPD, how likely would you be to seek additional information about Desyflux from a source other than your health care provider? [Interest/information seeking intention]


Variable Label: Q28: If you were diagnosed with COPD, how likely would you be to seek additional information about Desyflux from a source other than your health care provider?


Value

Value Label

01

Very unlikely

02

Somewhat unlikely

03

Neither likely nor unlikely

04

Somewhat likely

05

Very likely

-99

Refused

-100

Valid skip





Question Type: Single Punch

  1. If you were diagnosed with COPD, how likely would you be to ask your doctor for more information about Desyflux? [Behavioral intention]


Variable Label: Q27: If you were diagnosed with COPD, how likely would you be to ask your doctor for more information about Desyflux?


Value

Value Label

01

Very unlikely

02

Somewhat unlikely

03

Neither likely nor unlikely

04

Somewhat likely

05

Very likely

-99

Refused

-100

Valid skip




Question Type: Single Punch

  1. Based on the ad, how strong would you say the scientific evidence is for Desyflux’s effectiveness? [Assessment of evidence]


Variable Label: Q29: Based on the ad, how strong would you say the scientific evidence is for Desyflux’s effectiveness?


Value

Value Label

01

Very weak

02

Somewhat weak

03

Neither weak nor strong

04

Somewhat strong

05

Very strong

-99

Refused

-100

Valid skip




Question Type: Grid

  1. Which of the following statements appeared in the ad for Desyflux? Select all that apply. [Recall of claim and disclosure]


Variable Label: Q30: Which of the following statements appeared in the ad for Desyflux?


PROGRAMMER: Randomize order of all items


Variable Name

Variable Text

Variable Label

Q30_A

Results were not statistically significant

Q30_A: Results were not statistically significant

Q30_B

Goals of COPD treatment include maintaining lung function

Q30_B: Goals of COPD treatment include maintaining lung function

Q30_C

In clinical trials, people taking Desyflux saw an average increase of 2.5 percentage points in respiratory symptom score

Q30_C: In clinical trials, people taking Desyflux saw an average increase of 2.5 percentage points in respiratory symptom score

Q30_D

The observed effect may not be due to treatment with Desyflux

Q30_D: The observed effect may not be due to treatment with Desyflux

Q30_E

COPD may be exacerbated by smoking

Q30_E: COPD may be exacerbated by smoking

Q30_F

Do not take Desyflux if you are well controlled on another medication

Q30_F: Do not take Desyflux if you are well controlled on another medication


Value

Value Label

01

In ad

02

Not in ad

03

Don’t know

-99

Refused

-100

Valid skip



[Present Q31 and Q32 on same page]


Question Type: Single Punch

  1. How complicated would you say the information in the ad for Desyflux was? [Cognitive load]


Variable Label: Q31: How complicated would you say the information in the ad for Desyflux was?


Value

Value Label

01

Not at all complicated

02

Slightly complicated

03

Moderately complicated

04

Very complicated

05

Extremely complicated

-99

Refused

-100

Valid skip



Question Type: Single Punch

  1. How difficult was it to understand the Desyflux ad? [Cognitive load]


Variable Label: Q32: How difficult was it to understand the Desyflux ad?


Value

Value Label

01

Not at all difficult

02

Slightly difficult

03

Moderately difficult

04

Very difficult

05

Extremely difficult

-99

Refused

-100

Valid skip



PROGRAMMER: Block randomization ends here; resume standard survey flow


Question Type: Single Punch

  1. How likely is it that the benefits of the drugs presented in these promotional pieces are true? [Skepticism]


Variable Label: Q33: How likely is it that the benefits of the drugs presented in these promotional pieces are true?


Value

Value Label

01

Very unlikely

02

Somewhat unlikely

03

Neither likely nor unlikely

04

Somewhat likely

05

Very likely

-99

Refused

-100

Valid skip


Question Type: Single Punch

  1. How skeptical are you about the truth of the benefits of the drugs presented in these promotional pieces? [Skepticism]


Variable Label: Q34: How skeptical are you about the truth of the benefits of the drugs presented in these promotional pieces?


Value

Value Label

01

Not at all skeptical

02

Slightly skeptical

s03

Moderately skeptical

04

Very skeptical

05

Extremely skeptical

-99

Refused

-100

Valid skip


//DEMOGRAPHIC & PERSONAL INFORMATION//


Question Type: Multi-punch Grid

  1. Have you ever taken a prescription medication for (check all that apply): [Familiarity/exposure]


Variable Label: Q35: Have you ever taken a prescription medication for


Variable Name

Variable Text

Variable Label

Q35_A

High blood pressure

Q35_A: High blood pressure

Q35_B

COPD

Q35_B: COPD

Q35_C

Chronic iron overload

Q35_C: Chronic iron overload


Value

Value Label

00

True

01

False

-99

Refused

-100

Valid skip



Question Type: Multi-punch Grid

  1. Has a loved one (family member or close friend) ever taken a prescription medication for (check all that apply): [Familiarity/exposure]


Variable Label: Q34: Has a loved one (family member or close friend) ever taken a prescription medication for


Variable Name

Variable Text

Variable Label

Q34_A

High blood pressure

Q34_A: High blood pressure

Q34_B

COPD

Q34_B: COPD

Q34_C

Chronic iron overload

Q34_C: Chronic iron overload


Value

Value Label

00

True

01

False

-99

Refused

-100

Valid skip




//Closing for Ineligible Participants//


We’re sorry, but you are not eligible for this study. There are many possible reasons why people are not eligible. These reasons were decided earlier by the researchers. However, we thank you for your interest in this study and for taking the time to answer our questions today.




//Closing/Debrief for All Other Participants//


Thank you for your participation in this study; we appreciate your time and effort. Your participation helps us and the U.S. Department of Health and Human Services learn more about how people read and understand prescription drug advertisements.


The ads that you saw today were not for real prescription drugs. If you have questions or concerns about medical conditions, including high blood pressure, COPD, or chronic iron overload, or about prescription drugs to help treat these conditions, please talk to your doctor or other health care professional.


Healthcare Professional Pretest Questionnaire

Programmer Notes


Participants should not be able to go back in the survey, only forward.


Unless otherwise indicated, only one question should appear per screen.


Require an answer to all screener questions. Prompt for an answer to all other questions: “Are you sure you don’t want to provide a response?”


For all Likert scale questions, flip scale for half of participants (randomize); scale orientation should be consistent for each respondent (e.g., a respondent should see either all high/positive options on the left or all low/negative options on the left).



//MAIN STUDY INTRODUCTION TEXT//


INTRODUCTION

Thank you for agreeing to participate in this study today. This study is about advertisements for prescription medications. We will show you some ads and then ask you some questions about them. If you typically wear glasses or contacts for reading or using a computer or mobile device, please make sure to wear them while viewing these materials. Please maximize your browser window so you can easily view the ads.



//NEW SCREEN//


INSTRUCTIONS

You will now see a series of three pages taken from promotional brochures for medications used to treat some health conditions that may affect your patients. Please take a few moments to read and think about each page as it is shown.


PROGRAMMER:

  • Randomize the following blocks: Zoridtic, Eproquant, Desyflux (each block includes an ad followed by an assortment of questions).

  • Randomize disclosure condition within each drug type (each disclosure condition should be shown an equal number of times for each drug).

  • Show each ad for 30 seconds, then show a “Next” button for participants to advance at their own pace.

  • For all questions about a specific drug, show the logo of the relevant drug at the top of the screen. Placement should be consistent for each question and each drug.

  • Omit internal notes (shown in red).

  • Additional data required for each participant:

    • Device type

    • Operating system

    • Browser type

    • Resolution (when possible)

    • Amount of time spent on each ad (in seconds)

    • Ad order for each ad

    • Disclosure condition for each ad

    • Page and question order as noted throughout



//ZORIDTIC BLOCK//


//NEW SCREEN//


BLOCK INSTRUCTIONS

Click the blue button when you are ready to view the next ad. After 30 seconds, a button will appear to allow you to advance, but please take as long as you need to view the ad. You can move your mouse over the ad to magnify any area.


//NEW SCREEN//


PROGRAMMER: Show randomly assigned Zoridtic ad for 30 seconds, then show a “Next” button for participants to advance at their own pace



//NEW SCREEN//


Question Type: Single Punch

  1. Were you able to see and read the Zoridtic ad on your device?


Variable Label: Q1: Were you able to see and read the Zoridtic ad on your device?


Value

Value Label

00

No [Go to demographic Qs before terminating]

01

Yes

-99

Refused [Terminate]



//NEW SCREEN//


We are now going to ask you some questions about Zoridtic. Please answer the following questions and provide as much detail as possible where appropriate. Even if you don’t remember some information about Zoridtic, please try your best to answer all of the questions.


Question Type: Essay

  1. According to the ad, what is Zoridtic used for? [Unaided Recall]


Variable Label: Q2: According to the ad, what is Zoridtic used for?


Value

Value Label

-99

Refused

-100

Valid skip



Question Type: Essay

  1. What, if anything, did the ad mention Zoridtic is not approved for? [Unaided Recall]


Variable Label: Q3: What, if anything, did the ad mention Zoridtic is not approved for?


Value

Value Label

-99

Refused

-100

Valid skip




[Randomize order of Q4/Q5 page and Q6/Q7 page; record order]


[Present Q4 and Q5 on same page]


Question Type: Single Punch

  1. Based on the ad, how effective do you think Zoridtic would be for helping your patients control their high blood pressure? [Efficacy]


Variable Label: Q4: Based on the ad, how effective do you think Zoridtic would be for helping your patients control their high blood pressure?


Value

Value Label

01

Not at all effective

02

Slightly effective

03

Moderately effective

04

Mostly effective

05

Completely effective

-99

Refused

-100

Valid skip



Question Type: Single Punch

  1. Compared to most other prescription medications for high blood pressure, how effective would you say Zoridtic is? [Comparative efficacy]


Variable Label: Q5: Compared to most other prescription medications for high blood pressure, how effective would you say Zoridtic is?


Value

Value Label

01

Much less effective

02

Less effective

03

About the same

04

More effective

05

Much more effective

-99

Refused

-100

Valid skip





[Present Q6 and Q7 on same page]


Question Type: Single Punch

  1. Based on the ad, how effective do you think Zoridtic would be for helping your patients prevent a heart attack or stroke? [False claim perceptions]


Variable Label: Q6: Based on the ad, how effective do you think Zoridtic would be for helping your patients prevent a heart attack or stroke?


Value

Value Label

01

Not at all effective

02

Slightly effective

03

Moderately effective

04

Mostly effective

05

Completely effective

-99

Refused

-100

Valid skip



Question Type: Single Punch

  1. Compared to most other prescription medications to help prevent heart attack and stroke, how effective would you say Zoridtic is? [False claim comparative perceptions]


Variable Label: Q7: Compared to most other prescription medications to help prevent heart attack and stroke, how effective would you say Zoridtic is?


Value

Value Label

01

Much less effective

02

Less effective

03

About the same

04

More effective

05

Much more effective

-99

Refused

-100

Valid skip




[Randomize order of Q8–Q9; record order]


Question Type: Single Punch

  1. If you diagnosed a patient with high blood pressure, how likely would you be to seek additional information about Zoridtic when making a treatment decision for that patient? [Interest/information seeking intention]


Variable Label: Q8: If you diagnosed a patient with high blood pressure, how likely would you be to seek additional information about Zoridtic when making a treatment decision for that patient?


Value

Value Label

01

Very unlikely

02

Somewhat unlikely

03

Neither likely nor unlikely

04

Somewhat likely

05

Very likely

-99

Refused

-100

Valid skip




Question Type: Single Punch

  1. If a patient were at elevated risk for heart attack or stroke, how likely would you be to seek additional information about Zoridtic when making a treatment decision for that patient? [Interest/information seeking intention – incorrect]


Variable Label: Q9: If a patient were at elevated risk for heart attack or stroke, how likely would you be to seek additional information about Zoridtic when making a treatment decision for that patient?


Value

Value Label

01

Very unlikely

02

Somewhat unlikely

03

Neither likely nor unlikely

04

Somewhat likely

05

Very likely

-99

Refused

-100

Valid skip




[Randomize order of Q10–Q11; record order]


Question Type: Single Punch

  1. When treating a patient with high blood pressure who is not optimized on current drug therapy, how likely would you be to prescribe Zoridtic, alone or in combination with other therapy? For the purpose of this question, you may assume that Zoridtic is a formulary drug. [Behavioral intention]


Variable Label: Q10: When treating a patient with high blood pressure who is not optimized on current drug therapy, how likely would you be to prescribe Zoridtic, alone or in combination with other therapy? For the purpose of this question, you may assume that Zoridtic is a formulary drug.


Value

Value Label

01

Very unlikely

02

Somewhat unlikely

03

Neither likely nor unlikely

04

Somewhat likely

05

Very likely

-99

Refused

-100

Valid skip



Question Type: Single Punch

  1. When treating a patient at elevated risk for a heart attack or stroke, how likely would you be to prescribe Zoridtic, alone or in combination with other therapy? For the purpose of this question, you may assume that Zoridtic is a formulary drug. [Behavioral intention – incorrect]


Variable Label: Q11: When treating a patient at elevated risk for a heart attack or stroke, how likely would you be to prescribe Zoridtic, alone or in combination with other therapy? For the purpose of this question, you may assume that Zoridtic is a formulary drug.


Value

Value Label

01

Very unlikely

02

Somewhat unlikely

03

Neither likely nor unlikely

04

Somewhat likely

05

Very likely

-99

Refused

-100

Valid skip





Question Type: Grid

  1. Which of the following statements appeared in the ad for Zoridtic? Select all that apply. [Recognition of claim and disclosure]


PROGRAMMER: Randomize order of all items


Variable Name

Variable Text

Variable Label

Q12_A

Zoridtic has not been tested as treatment or prevention for cardiovascular events, including heart attack and stroke

Q12_A: Zoridtic has not been tested as treatment or prevention for cardiovascular events, including heart attack and stroke

Q12_B

Zoridtic can significantly lower high blood pressure within 2 weeks

Q12_B: Zoridtic can significantly lower high blood pressure within 2 weeks

Q12_C

Medications that lower blood pressure also lower risk for heart attack and stroke

Q12_C: Medications that lower blood pressure also lower risk for heart attack and stroke

Q12_D

Zoridtic has not been approved to treat or prevent these events

Q12_D: Zoridtic has not been approved to treat or prevent these events

Q12_E

Do not prescribe Zoridtic for patients with diabetes

Q12_E: Do not prescribe Zoridtic for patients with diabetes

Q12_F

Zoridtic may cause headaches or dizziness

Q12_F: Zoridtic may cause headaches or dizziness



Value

Value Label

01

In ad

02

Not in ad

03

Don’t know

-99

Refused

-100

Valid skip





[Present Q13 and Q14 on same page]


Question Type: Single Punch

  1. How complicated would you say the information in the ad for Zoridtic was? [Cognitive load]


Variable Label: Q13: How complicated would you say the information in the ad for Zoridtic was?


Value

Value Label

01

Not at all complicated

02

Slightly complicated

03

Moderately complicated

04

Very complicated

05

Extremely complicated

-99

Refused

-100

Valid skip



Question Type: Single Punch

  1. How difficult was it to understand the Zoridtic ad? [Cognitive load]


Variable Label: Q14: How difficult was it to understand the Zoridtic ad?


Value

Value Label

01

Not at all difficult

02

Slightly difficult

03

Moderately difficult

04

Very difficult

05

Extremely difficult

-99

Refused

-100

Valid skip





//EPROQUANT BLOCK//


//NEW SCREEN//


BLOCK INSTRUCTIONS

Click the blue button when you are ready to view the next ad. After 30 seconds, a button will appear to allow you to advance, but please take as long as you need to view the ad. You can move your mouse over the ad to magnify any area.


//NEW SCREEN//

PROGRAMMER: Show randomly assigned Eproquant ad for 30 seconds, then show a “Next” button for participants to advance at their own pace


//NEW SCREEN//


Question Type: Single Punch

  1. Were you able to see and read the Eproquant ad on your device?


Variable Label: Q15: Were you able to see and read the Eproquant ad on your device?


Value

Value Label

00

No [Go to demographic Qs before terminating]

01

Yes

-99

Refused [Terminate]



//NEW SCREEN//


We are now going to ask you some questions about Eproquant. Please answer the following questions and provide as much detail as possible where appropriate. Even if you don’t remember some information about Eproquant, please try your best to answer all of the questions.


Question Type: Essay

  1. According to the ad, what is Eproquant used for? [Unaided Recall]


Variable Label: Q16: According to the ad, what is Eproquant used for?


Value

Value Label

-99

Refused

-100

Valid skip




Question Type: Essay

  1. What instructions, if any, did the ad mention for taking Eproquant? [Unaided Recall]


Variable Label: Q17: What instructions, if any, did the ad mention for taking Eproquant?


Value

Value Label

-99

Refused

-100

Valid skip



Question Type: Single Punch

  1. Based on the ad, how easy or hard do you think it would be for a patient with chronic iron overload to use Eproquant to help control his or her iron levels? [Ease of use]


Variable Label: Q18: Based on the ad, how easy or hard do you think it would be for a patient with chronic iron overload to use Eproquant to help control his or her iron levels?


Value

Value Label

01

Very hard

02

Somewhat hard

03

Neither easy nor hard

04

Somewhat easy

05

Very easy

-99

Refused

-100

Valid skip



Question Type: Single Punch

  1. Based on the ad, how easy or hard do you think it would be for your patients to make Eproquant part of their daily routine? [Ease of use]


Variable Label: Q19: Based on the ad, how easy or hard do you think it would be for your patients to make Eproquant part of their daily routine?


Value

Value Label

01

Very hard

02

Somewhat hard

03

Neither easy nor hard

04

Somewhat easy

05

Very easy

-99

Refused

-100

Valid skip





Question Type: Single Punch

  1. If you diagnosed a patient with chronic iron overload, how likely would you be to seek additional information about Eproquant when making a treatment decision for that patient? [Interest/information seeking intention]


Variable Label: Q20: If you diagnosed a patient with chronic iron overload, how likely would you be to seek additional information about Eproquant when making a treatment decision for that patient?


Value

Value Label

01

Very unlikely

02

Somewhat unlikely

03

Neither likely nor unlikely

04

Somewhat likely

05

Very likely

-99

Refused

-100

Valid skip




Question Type: Single Punch

  1. If you were treating a patient with chronic iron overload, how likely would you be to prescribe Eproquant? Assume that you yourself are treating the patient, rather than referring to a specialist, and that Eproquant is a formulary drug. [Behavioral intention]


Variable Label: Q21: If you were treating a patient with chronic iron overload, how likely would you be to prescribe Eproquant? Assume that you yourself are treating the patient, rather than referring to a specialist, and that Eproquant is a formulary drug.


Value

Value Label

01

Very unlikely

02

Somewhat unlikely

03

Neither likely nor unlikely

04

Somewhat likely

05

Very likely

-99

Refused

-100

Valid skip




Question Type: Grid

  1. Which of the following statements appeared in the ad for Eproquant? Select all that apply. [Recognition of claim and disclosure]


PROGRAMMER: Randomize order of all items


Variable Name

Variable Text

Variable Label

Q22_A

For best results, Eproquant should be taken with water and a light meal or snack

Q22_A: For best results, Eproquant should be taken with water and a light meal or snack

Q22_B

Both Eproquant and Bravaset should be taken every day, preferably at the same time each day

Q22_B: Both Eproquant and Bravaset should be taken every day, preferably at the same time each day

Q22_C

Eproquant is a simple to take, once-daily tablet

Q22_C: Eproquant is a simple to take, once-daily tablet

Q22_D

Do not take Eproquant without 8 oz. of water. Do not take Eproquant without food containing <7% fat and about 250 calories.

Q22_D: Do not take Eproquant without 8 oz. of water. Do not take Eproquant without food containing <7% fat and about 250 calories.

Q22_E

Eproquant should not be taken concurrently with Evitronir

Q22_E: Eproquant should not be taken concurrently with Evitronir

Q22_F

The easier chelation regimen for patients with chronic iron overload

Q22_F: The easier chelation regimen for patients with chronic iron overload



Value

Value Label

01

In ad

02

Not in ad

03

Don’t know

-99

Refused

-100

Valid skip



[Present Q23 and Q24 on same page]


Question Type: Single Punch

  1. How complicated would you say the information in the ad for Eproquant was? [Cognitive load]


Variable Label: Q23: How complicated would you say the information in the ad for Eproquant was?


Value

Value Label

01

Not at all complicated

02

Slightly complicated

03

Moderately complicated

04

Very complicated

05

Extremely complicated

-99

Refused

-100

Valid skip



Question Type: Single Punch

  1. How difficult was it to understand the Eproquant ad? [Cognitive load]


Variable Label: Q24: How difficult was it to understand the Eproquant ad?


Value

Value Label

01

Not at all difficult

02

Slightly difficult

03

Moderately difficult

04

Very difficult

05

Extremely difficult

-99

Refused

-100

Valid skip





//DESYFLUX BLOCK//


//NEW SCREEN//


BLOCK INSTRUCTIONS

Click the blue button when you are ready to view the next ad. After 30 seconds, a button will appear to allow you to advance, but please take as long as you need to view the ad. You can move your mouse over the ad to magnify any area.



//NEW SCREEN//


PROGRAMMER: Show randomly assigned Desyflux ad for 30 seconds, then show a “Next” button for participants to advance at their own pace



//NEW SCREEN//


Question Type: Single Punch

  1. Were you able to see and read the Desyflux ad on your device?


Variable Label: Q25: Were you able to see and read the Desyflux ad on your device?


Value

Value Label

00

No [Go to demographic Qs before terminating]

01

Yes

-99

Refused [Terminate]



//NEW SCREEN//


We are now going to ask you some questions about Desyflux. Please answer the following questions and provide as much detail as possible where appropriate. Even if you don’t remember some information about Desyflux, please try your best to answer all of the questions.


Question Type: Essay

  1. According to the ad, what is Desyflux used for? [Unaided Recall]


Variable Label: Q26: According to the ad, what is Desyflux used for?


Value

Value Label

-99

Refused

-100

Valid skip




Question Type: Essay

  1. What effects, if any, did Desyflux have in clinical trials? [Unaided Recall/Comprehension]


Variable Label: Q27: What effects, if any, did Desyflux have in clinical trials?


Value

Value Label

-99

Refused

-100

Valid skip



[Present Q28 and Q29 on same page]


Question Type: Single Punch

  1. Based on the ad, how effective do you think Desyflux would be for improving a patient’s lung function if he or she had COPD? [Efficacy]


Variable Label: Q28: Based on the ad, how effective do you think Desyflux would be for improving a patient’s lung function if he or she had COPD?


Value

Value Label

01

Not at all effective

02

Slightly effective

03

Moderately effective

04

Mostly effective

05

Completely effective

-99

Refused

-100

Valid skip



Question Type: Single Punch

  1. Compared to most other prescription medications for COPD, how effective would you say Desyflux is? [Comparative efficacy]


Variable Label: Q29: Compared to most other prescription medications for COPD, how effective would you say Desyflux is?


Value

Value Label

01

Much less effective

02

Less effective

03

About the same

04

More effective

05

Much more effective

-99

Refused

-100

Valid skip




Question Type: Single Punch

  1. If you diagnosed a patient with COPD caused by Alpha-1 Antitrypsin Deficiency, how likely would you be to seek additional information about Desyflux when making a treatment decision for that patient? Assume that you yourself are treating the patient, rather than referring to a specialist. [Interest/information seeking intention]


Variable Label: Q30: If you diagnosed a patient with COPD caused by Alpha-1 Antitrypsin Deficiency, how likely would you be to seek additional information about Desyflux when making a treatment decision for that patient? Assume that you yourself are treating the patient, rather than referring to a specialist.


Value

Value Label

01

Very unlikely

02

Somewhat unlikely

03

Neither likely nor unlikely

04

Somewhat likely

05

Very likely

-99

Refused

-100

Valid skip



Question Type: Single Punch

  1. If you were treating a patient with COPD caused by Alpha-1 Antitrypsin Deficiency, how likely would you be to prescribe Desyflux? Assume that you yourself are treating the patient, rather than referring to a specialist. [Behavioral intention]


Variable Label: Q31: If you were treating a patient with COPD caused by Alpha-1 Antitrypsin Deficiency, how likely would you be to prescribe Desyflux? Assume that you yourself are treating the patient, rather than referring to a specialist.


Value

Value Label

01

Very unlikely

02

Somewhat unlikely

03

Neither likely nor unlikely

04

Somewhat likely

05

Very likely

-99

Refused

-100

Valid skip




Question Type: Single Punch

  1. Based on the ad, how strong would you say the scientific evidence is for Desyflux’s effectiveness? [Assessment of evidence]


Variable Label: Q32: Based on the ad, how strong would you say the scientific evidence is for Desyflux’s effectiveness?


Value

Value Label

01

Very weak

02

Somewhat weak

03

Neither weak nor strong

04

Somewhat strong

05

Very strong

-99

Refused

-100

Valid skip



Question Type: Grid

  1. Which of the following appeared in the ad for Desyflux? Select all that apply. [Recognition of claim and disclosure]


PROGRAMMER: Randomize order of all items


Variable Name

Variable Text

Variable Label

Q33_A

p = .11

Q33_A: p = .11

Q33_B

Target the protein defects in patients with Alpha-1 Antitrypsin Deficiency (AATD)

Q33_B: Target the protein defects in patients with Alpha-1 Antitrypsin Deficiency (AATD)

Q33_C

Absolute change in percent predicted FEV1 at Week 24 (95% CI): 3.0 (1.6, 4.4)

Q33_C: Absolute change in percent predicted FEV1 at Week 24 (95% CI): 3.0 (1.6, 4.4)

Q33_D

Results were not statistically significant

Q33_D: Results were not statistically significant

Q33_E

Desyflux is approved as an alternative to Altiflux

Q33_E: Desyflux is approved as an alternative to Altiflux

Q33_F

Desyflux is not for patients well controlled on another medication

Q33_F: Desyflux is not for patients well controlled on another medication



Value

Value Label

01

In ad

02

Not in ad

03

Don’t know

-99

Refused

-100

Valid skip



PROGRAMMER: Ask Q34 if Q33_A=01 or Q33_D=01


Question Type: Single Punch

  1. How much did [PIPE IN Q33_A OR Q33_D AS SELECTED BY PARTICIPANT; DISPLAY IN BOLD FONT] influence your assessment of the scientific evidence for Desyflux? [Effect of disclosure]


Variable Label: Q34: How much did the statement [disclosure] influence your assessment of the scientific evidence for [D]esyflux?


Value

Value Label

01

Not at all

02

Slightly

03

Moderately

04

Very much

05

Extremely

-99

Refused

-100

Valid skip



PROGRAMMER: Ask Q35 if [Q33_A=02 or 03 or -99]


Question Type: Single Punch

  1. If you had seen the statement below, how much would it have influenced your assessment of the scientific evidence for Desyflux? [Effect of disclosure]


p = .11


Variable Label: Q35: If you had seen the statement below, how much would it have influenced your assessment of the scientific evidence for Desyflux?


Value

Value Label

01

Not at all

02

Slightly

03

Moderately

04

Very much

05

Extremely

-99

Refused

-100

Valid skip





[Present Q36 and Q37 on same page]


Question Type: Single Punch

  1. How complicated would you say the information in the ad for Desyflux was? [Cognitive load]


Variable Label: Q36: How complicated would you say the information in the ad for Desyflux was?


Value

Value Label

01

Not at all complicated

02

Slightly complicated

03

Moderately complicated

04

Very complicated

05

Extremely complicated

-99

Refused

-100

Valid skip



Question Type: Single Punch

  1. How difficult was it to understand the Desyflux ad? [Cognitive load]


Variable Label: Q37: How difficult was it to understand the Desyflux ad?


Value

Value Label

01

Not at all difficult

02

Slightly difficult

03

Moderately difficult

04

Very difficult

05

Extremely difficult

-99

Refused

-100

Valid skip




PROGRAMMER: Block randomization ends here; resume standard survey flow



Question Type: Single Punch

  1. How likely is it that the benefits of the drugs presented in these promotional pieces are true? [Skepticism]


Variable Label: Q38: How likely is it that the benefits of the drugs presented in these promotional pieces are true?


Value

Value Label

01

Very unlikely

02

Somewhat unlikely

03

Neither likely nor unlikely

04

Somewhat likely

05

Very likely

-99

Refused

-100

Valid skip


Question Type: Single Punch

  1. How skeptical are you about the truth of the benefits of the drugs presented in these promotional pieces? [Skepticism]


Variable Label: Q39: How skeptical are you about the truth of the benefits of the drugs presented in these promotional pieces?


Value

Value Label

01

Not at all skeptical

02

Slightly skeptical

s03

Moderately skeptical

04

Very skeptical

05

Extremely skeptical

-99

Refused

-100

Valid skip



//DEMOGRAPHIC & PERSONAL INFORMATION//


Question Type: Multi-punch

  1. Which of the following advanced degrees have you received? Select all that apply.


Variable Label: Q38: Which of the following advanced degrees have you received?


Value

Value Label

01

MD

02

PhD

03

DO

04

DCM

05

DMSc

06

Other

-99

Refused

-100

Valid skip



Question Type: Single Punch

  1. How confident are you in your ability to understand data from clinical trials for prescription drugs?


Variable Label: Q39: How confident are you in your ability to understand data from clinical trials for prescription drugs?


Value

Value Label

01

Not at all confident

02

Slightly confident

03

Moderately confident

04

Very confident

05

Extremely confident

-99

Refused

-100

Valid skip



Question Type: Single Punch

  1. How frequently do you encounter promotional materials for prescription drugs?


Variable Label: Q40: How frequently do you encounter promotional materials for prescription drugs?


Value

Value Label

01

Never

02

Rarely

03

Sometimes

04

Often

05

Very often

-99

Refused

-100

Valid skip

//Closing for Ineligible Participants//


We’re sorry, but you are not eligible for this study. There are many possible reasons why people are not eligible. These reasons were decided earlier by the researchers. However, we thank you for your interest in this study and for taking the time to answer our questions today.



//Closing/Debrief for All Other Participants//


Thank you for your participation in this study; we appreciate your time and effort. Your participation helps us and the U.S. Department of Health and Human Services learn more about how health care providers read and understand prescription drug advertisements.


The ads that you saw today were created for the purposes of this study and are not for real prescription drugs.






32



File Typeapplication/vnd.openxmlformats-officedocument.wordprocessingml.document
AuthorO'Donoghue, Amie
File Modified0000-00-00
File Created2021-01-20

© 2024 OMB.report | Privacy Policy